Ads
related to: latest updates on multiple sclerosis research paper articles- Treatment FAQs
See Frequently Asked
Questions. Get The Answers.
- Patient Stories
See What Real Patients
Are Saying About This Treatment.
- Clinical Results
View The Results Of
Clinical Studies Here.
- Relapsing MS Treatment
Learn About A RMS
Treatment Option.
- Financial Resources
See Financial & Savings Info.
Learn About Savings Options.
- Patient Resources
Download Resources To
Learn More About Treatment.
- Treatment FAQs
Search results
Results From The WOW.Com Content Network
The Multiple Sclerosis Journal (formerly Multiple Sclerosis) is a monthly peer-reviewed medical journal covering the clinical neurology of multiple sclerosis. The editor-in-chief is Alan J Thompson (University College London). It was established in 1995 and is published by SAGE Publications. [1]
Research in multiple sclerosis may find new pathways to interact with the disease, improve function, curtail attacks, or limit the progression of the underlying disease. Many treatments already in clinical trials involve drugs that are used in other diseases or medications that have not been designed specifically for multiple sclerosis .
[46] [47] Research in this area has focused on the efficacy of estriol as a treatment to reduce symptoms of relapse-remitting multiple sclerosis in non-pregnant women. [48] [49] [50] ibudilast: A phase II trial shows that Ibudilast does not reduce lesion rate, but prevents them to turn into black holes.
Nearly 2.3 million people are estimated to be living with multiple sclerosis around the world, but when Montel Williams received his official diagnosis back in 1999, not much was known about the ...
Comparative Effectiveness Research (CER) is an emerging field in Multiple Sclerosis treatment. The response of the disease to the different available medications at this moment cannot be predicted, and would be desirable. [17] But the ideal target is to find subtypes of the disease that respond better to a specific treatment.
In multiple sclerosis, inflammation, demyelination, and neurodegeneration are observed together. Some clinical trials have shown that the inflammation produces both the relapses and the demyelination, and that neurodegeneration (axonal transection) is independent from inflammation, produces the accumulative disability, and advances even when ...
Ads
related to: latest updates on multiple sclerosis research paper articles